Fulcrum Therapeutics Third Quarter 2024 Earnings: US$0.35 loss per share (vs US$0.39 loss in 3Q 2023)
Net loss: US$21.7m (loss narrowed by 9.7% from 3Q 2023). US$0.35 loss per share (improved from US$0.39 loss in 3Q 2023). All ...